| Literature DB >> 34383759 |
Bénédicte Melot1,2, Gauthier Delvallez3, Ann-Claire Gourinat3, Nicolas Molko4, Cyrille Goarant2, Yves-Marie Ducrot5, Emilie Huguon6, Cécile Cazorla7, Martine Chauvet3, Antoine Biron3, Julien Colot2,3.
Abstract
INTRODUCTION: Eosinophilic meningitis is a rare form of meningitis with sequelae or death occurring in approximately 2-3% of cases. The most frequent etiological agent is the parasite Angiostrongylus cantonensis. The aim of this study was to characterize New Caledonian cases and to assess the extent to which of A. cantonensis was involved.Entities:
Mesh:
Year: 2021 PMID: 34383759 PMCID: PMC8360557 DOI: 10.1371/journal.pone.0254964
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Socio-demographical features of New Caledonian cases of EM from 2004 to 2019 according to severity, n = 92.
| Variables | Total | Severe | Non severe | Crude OR | 95% CI | P value | |||
|---|---|---|---|---|---|---|---|---|---|
| N = 92 | % | N = 29 | % | N = 63 | % | ||||
| Age | 1.03 | 1.01–1.06 | 0.005 | ||||||
| Mean (SD) | 25 | 34.2 (22.7) | 20.7 (18) | ||||||
| Median (IQR) | 22.5 | 36 (27) | 15 (30.5) | ||||||
| Age class (years old) | 0.03 | ||||||||
| 0–4 | 22 | 23.9 | 5 | 17.2 | 17 | 27 | |||
| 5–18 | 19 | 20.7 | 2 | 6.9 | 17 | 27 | 0.4 | 0.07–2.35 | 0.31 |
| 19–25 | 7 | 7.6 | 3 | 10.3 | 4 | 6.3 | 2.55 | 0.4–15.4 | 0.3 |
| >25 | 44 | 47.8 | 19 | 65.5 | 25 | 39.7 | 2.58 | 0.8–8.26 | 0.11 |
| Sex masculine | 0.94 | 0.38–2.33 | 0.9 | ||||||
| No | 34 | 37.0 | 11 | 37.9 | 23 | 36.5 | |||
| Yes | 58 | 63.0 | 8 | 62.1 | 40 | 63.5 | |||
| Melanesian | 1.02 | 0.32–3.25 | 0.98 | ||||||
| No | 16 | 17.4 | 5 | 17.2 | 11 | 17.5 | |||
| Yes | 76 | 82.6 | 24 | 82.8 | 52 | 82.5 | |||
| Rural | 1.0 | 0.33–2.9 | 0.99 | ||||||
| No | 19 | 20.7 | 6 | 20.7 | 13 | 20.6 | |||
| Yes | 73 | 79.3 | 23 | 79.3 | 50 | 79.4 | |||
| Province | 0.05 | ||||||||
| Islands | 12 | 13.0 | 2 | 6.9 | 10 | 15.9 | 0.12 | 0.01–0.97 | |
| North | 28 | 30.4 | 12 | 41.4 | 16 | 25.4 | 0.45 | 0.09–2.26 | |
| South | 44 | 47.8 | 10 | 34.5 | 34 | 54.0 | 0.18 | 0.04–0.87 | |
| Others (Vanuatu, Wallis) | 8 | 8.7 | 5 | 17.2 | 3 | 4.8 | |||
| Seasonality | 0.92 | 0.38–2.24 | 0.85 | ||||||
| May-October | 52 | 56.5 | 16 | 55.2 | 36 | 57.1 | |||
| November-April | 40 | 43.5 | 13 | 44.8 | 27 | 42.9 | |||
* OR = odds ratio.
** CI = confidence interval.
Biological features of the New Caledonian cases of EM from 2004 to 2019 according to severity, n = 92.
| Variables | Total | Severe | Not severe | Crude OR | 95% CI | P value | |||
|---|---|---|---|---|---|---|---|---|---|
| N = 92 | % | N = 29 | % | N = 63 | % | ||||
| % CSF eosinophils | 1 | 0.99–1.03 | 0.42 | ||||||
| Mean (SD) | 37.3 | 40.2 (24.3) | 36.0 (22.7) | ||||||
| Median (IQR) | 32 | 36 (36) | 31(36) | ||||||
| CSF eosinophils >40% | 1.32 | 0.54–3.22 | 0.37 | ||||||
| No | 55 | 60.0 | 16 | 55.2 | 39 | 61.9 | |||
| Yes | 37 | 40.0 | 13 | 44.8 | 24 | 38.1 | |||
| CSF GB (/mm3) | 1 | 0.99–1 | 0.4 | ||||||
| Mean (SD) | 558 | 486 (330) | 591 (638) | ||||||
| Median (IQR) | 480 | 399 (440) | 500 (782) | ||||||
| CSF proteins (g/L) | 2 | 0.97–4.15 | 0.06 | ||||||
| Mean (SD) | 0.92 | 1.2 (1.2) | 0.8(0.45) | ||||||
| Median (IQR) | 0.76 | 0.87 (0.71) | 0.72 (0.52) | ||||||
| CSF proteins > 1 g | 1.8 | 0.7–4.6 | 0.22 | ||||||
| No | 65 | 70.7 | 18 | 62.1 | 47 | 74.6 | |||
| Yes | 27 | 29.3 | 11 | 37.9 | 16 | 25.4 | |||
| CSF glucose (mmol/L) | 1.58 | 0.92–2.72 | 0.1 | ||||||
| Mean (SD) | 2.73 | 2.9(1.04) | 2.63 (0.72) | ||||||
| Median (IQR) | 2.66 | 2.8 (1.15) | 2.6 (0.92) | ||||||
| Blood eosinophils (/mm3) | 1 | 0.99–1 | 0.68 | ||||||
| Mean (SD) | 1762 | 1853 (1565) | 1719 (1437) | ||||||
| Median (IQR) | 1270 | 1230 (2100) | 1280 (2070) | ||||||
| % blood eosinophils | 1.02 | 0.97–1.07 | 0.54 | ||||||
| Mean (SD) | 15.11 | 17 (12.8) | 14.2 (9.6) | ||||||
| Median (IQR) | 14.3 | 14.9 (15.1) | 13.7 (15.3) | ||||||
| Elevated CSF pressure | 3.07 | 0.76–12 | 0.11 | ||||||
| No | 83 | 90.2 | 24 | 82.8 | 59 | 93.7 | |||
| Yes | 9 | 9.8 | 5 | 17.2 | 4 | 6.3 | |||
| Positive serology | 0.6 | ||||||||
| No | 9 | 9.8 | 3 | 10.3 | 6 | 9.5 | |||
| Yes | 6 | 6.5 | 3 | 10.3 | 3 | 4.8 | 2 | 0.24–16.6 | 0.5 |
| Not performed | 77 | 83.7 | 23 | 79.3 | 54 | 85.7 | 1.78 | 0.2–3.7 | 0.8 |
| Positive CSF serology | 0.11 | ||||||||
| No | 7 | 7.6 | 1 | 3.4 | 6 | 9.5 | |||
| Yes | 4 | 4.3 | 3 | 10.3 | 1 | 1.6 | 18 | 0.81–400 | 0.07 |
| Not performed | 81 | 88.0 | 25 | 86.2 | 56 | 88.9 | 2.7 | 0.3–23.4 | 0.37 |
| Positive CSF PCR | 2.67 | 0.35 | |||||||
| No | 10 | 10.9 | 2 | 6.9 | 8 | 12.7 | |||
| Yes | 11 | 12 | 2 | 6.9 | 9 | 14.3 | 0.89 | 0.1–7.8 | 0.91 |
| Not Performed | 71 | 77.2 | 25 | 86.2 | 46 | 73.0 | 2.1 | 0.43–11 | 0.35 |
| Hyponatremia | 0.81 | 0.24–3.01 | 0.77 | ||||||
| No | 75 | 81.6 | 23 | 79.3 | 52 | 82.5 | |||
| Yes | 17 | 18.4 | 6 | 20.7 | 11 | 17.5 | |||
Radiological and other paraclinical features of New Caledonian cases of EM from 2004 to 2019 according to severity, n = 92.
| Variables | Total | Severe | Not severe | CrudeOR | 95% CI | P value | |||
|---|---|---|---|---|---|---|---|---|---|
| N = 92 | % | N = 29 | % | N = 63 | % | ||||
| Abnormal CT scan | 1.1 | 0.25–4.7 | 0.9 | ||||||
| No | 83 | 90.2 | 26 | 89.7 | 57 | 90.5 | |||
| Yes | 9 | 9.8 | 3 | 10.3 | 6 | 9.5 | |||
| Abnormal MRI | 0 | 0-inf | 1 | ||||||
| No | 87 | 94.6 | 23 | 82.8 | 63 | 100.0 | |||
| Yes | 5 | 5.4 | 5 | 17.2 | 0 | 0.0 | |||
| Abnormal EEG | 1.52 | 0.39–5.8 | 0.54 | ||||||
| No | 82 | 89.1 | 25 | 86.2 | 57 | 90.5 | |||
| Yes | 10 | 10.9 | 4 | 13.8 | 6 | 9.5 | |||
| Abnormal fundoscopic examination | 0 | 0-inf | 1 | ||||||
| No | 90 | 97.8 | 29 | 100.0 | 61 | 96.8 | |||
| Yes | 2 | 2.2 | 0 | 0.0 | 2 | 3.2 | |||
Fig 1Monthly distribution of the New-Caledonian cases according to average rainfall in mm in Noumea, from 2004 to 2019, n = 92.
Clinical features of New Caledonian cases of EM from 2004 to 2019 according to severity, n = 92.
| Variables | Total | Severe | Not severe | Crude OR | 95% CI | P value | |||
|---|---|---|---|---|---|---|---|---|---|
| N = 92 | % | N = 29 | % | N = 63 | % | ||||
| Duration of symptoms (d) | 2.23 | 1.5–2.9 | 0.02 | ||||||
| Mean (SD) | 12.73 | 20.7(28.1) | 8.9(7.7) | ||||||
| Median (IQR) | 7 | 15(14) | 6.25(8.9) | ||||||
| Duration of hospitalization (d) | 1.1 | 1.03–1.19 | 0.009 | ||||||
| Mean (SD) | 8.8 | 16.2 (28.6) | 5.4 (4.2) | ||||||
| Median (IQR) | 5 | 8 (10) | 4(4.5) | ||||||
| ICU | 1.7 | 0.23–10.7 | 0.6 | ||||||
| No | 85 | 92.4 | 26 | 89.7 | 59 | 93.7 | |||
| Yes | 7 | 7.6 | 3 | 10.3 | 4 | 6.3 | |||
| Headache | 0.93 | 0.38–2.28 | 0.87 | ||||||
| No | 37 | 40.2 | 12 | 41.4 | 25 | 39.7 | |||
| Yes | 55 | 59.8 | 17 | 58.6 | 38 | 60.3 | |||
| Fever | 1.96 | 0.76–5.05 | 0.16 | ||||||
| No | 66 | 71.7 | 18 | 62.1 | 48 | 76.2 | |||
| Yes | 26 | 28.3 | 11 | 37.9 | 15 | 23.8 | |||
| Crying | 0.53 | 0.06–4.9 | 0.57 | ||||||
| No | 87 | 94.6 | 28 | 96.6 | 59 | 93.7 | |||
| Yes | 5 | 5.4 | 1 | 3.4 | 4 | 6.3 | |||
| Deterioration of general condition | 0.6 | 0.2–1.7 | 0.34 | ||||||
| No | 67 | 72.8 | 23 | 79.3 | 44 | 69.8 | |||
| Yes | 25 | 27.2 | 6 | 20.7 | 19 | 30.2 | |||
| Grey complexion | 1.09 | 0.09–12.5 | 0.9 | ||||||
| No | 89 | 96.7 | 28 | 96.6 | 61 | 96.8 | |||
| Yes | 3 | 3.3 | 1 | 3.4 | 2 | 3.2 | |||
| Coma | 4.6 | 0.4–53 | 0.22 | ||||||
| No | 89 | 95.7 | 27 | 93.1 | 62 | 98.4 | |||
| Yes | 3 | 3.3 | 2 | 6.9 | 1 | 1.6 | |||
| Drowsiness | 0 | 0.-inf | 1 | ||||||
| No | 88 | 95.7 | 29 | 100.0 | 59 | 93.7 | |||
| Yes | 4 | 4.3 | 0 | 0.0 | 4 | 6.3 | |||
| Vomiting | 0.37 | 0.14–1 | 0.05 | ||||||
| No | 56 | 60.9 | 22 | 75.9 | 34 | 54.0 | |||
| Yes | 36 | 39.1 | 7 | 24.1 | 29 | 46.0 | |||
| Stiff neck | 0.16 | 0.03–0.74 | 0.02 | ||||||
| No | 70 | 76.1 | 27 | 93.1 | 43 | 68.3 | |||
| Yes | 22 | 23.9 | 2 | 6.9 | 20 | 6.9 | |||
| Convulsion | 3.8 | 1–15 | 0.05 | ||||||
| No | 82 | 89.1 | 23 | 79.3 | 59 | 93.7 | |||
| Yes | 10 | 10.9 | 6 | 20.7 | 4 | 6.3 | |||
Treatment of New Caledonian cases of EM according to severity, n = 92.
| Variables | Total | Severe | Not severe | Crude OR | 95% CI | P value | |||
|---|---|---|---|---|---|---|---|---|---|
| N = 92 | % | N = 29 | % | N = 63 | % | ||||
| Albendazole | 1.1 | 0.43–2.93 | 0.81 | ||||||
| No | 65 | 70.07 | 20 | 69.0 | 45 | 71.4 | |||
| Yes | 27 | 29.3 | 9 | 31.0 | 18 | 28.6 | |||
| Duration of albendazole (d) | 0.39 | ||||||||
| Mean | 3.9 | 6 (7.3) | 3.2 (1.1) | ||||||
| Median | 3 | 3 (0) | 3 (0) | ||||||
| Ivermectin | 0.53 | 0.06–4.93 | 0.57 | ||||||
| No | 87 | 94.6 | 28 | 96.6 | 59 | 93.7 | |||
| Yes | 5 | 5.4 | 1 | 3.4 | 4 | 6.3 | |||
| Duration of ivermectin (d) | 0.7 | ||||||||
| Mean | 2.8 | 2(0) | 3 (2.8) | ||||||
| Median | 2 | 2(0) | 2 (3) | ||||||
| Steroids | 2.55 | 0.8–8.1 | 0.11 | ||||||
| No | 78 | 84.8 | 22 | 75.9 | 56 | 88.9 | |||
| Yes | 14 | 15.2 | 7 | 24.1 | 7 | 11.1 | |||
| Duration of steroids (d) | 1.6 | 0.11 | |||||||
| Mean | 26.6 | 41 (34) | 11 (11) | ||||||
| Median | 15 | 30 (45) | 9 (12) | ||||||
| Antibiotics | 1.1 | 0.3–4 | 0.88 | ||||||
| No | 80 | 87.0 | 25 | 86.2 | 55 | 87.3 | |||
| Yes | 12 | 13.0 | 4 | 13.8 | 8 | 12.7 | |||
Final model of New Caledonian cases of EM according to death/sequelae, n = 92.
| Variables | Total | Death/sequelae | Without sequelae | Adjusted OR | 95% CI | P value | |||
|---|---|---|---|---|---|---|---|---|---|
| N = 92 | % | N = 29 | % | N = 63 | % | ||||
| Encephalitis | 1.27 | 0.7–1.25 | 0.87 | ||||||
| No | 81 | 88.0 | 13 | 76.5 | 68 | 90.7 | |||
| Yes | 11 | 12.0 | 4 | 23.5 | 7 | 9.3 | |||
| Radiculitis | 1.2 | 0.94–1.5 | 0.13 | ||||||
| No | 74 | 80.4 | 10 | 58.8 | 64 | 85.3 | |||
| Yes | 18 | 19.6 | 7 | 41.2 | 11 | 14.7 | |||
| Cranial radiculitis | 1.18 | 0.87–1.6 | 0.26 | ||||||
| No | 81 | 88 | 11 | 64.7 | 70 | 93.3 | |||
| Yes | 11 | 12 | 6 | 35.3 | 5 | 6.7 | |||
| Positive serology in CSF | 0.8 | 0.48–1.3 | 0.36 | ||||||
| No | 7 | 7.6 | 1 | 5.9 | 6 | 8.0 | |||
| Yes | 4 | 4.3 | 2 | 11.8 | 2 | 2.7 | |||
| Not performed | 81 | 88.0 | 14 | 82.4 | 67 | 89.3 | |||
| Modified MRI | 1.5 | 1–2.3 | 0.05 | ||||||
| No | 87 | 94.6 | 13 | 76.5 | 74 | 98.7 | |||
| Yes | 5 | 5.4 | 4 | 23.5 | 1 | 1.3 | |||
| Steroids | 1.4 | 1.1–1.7 | 0.0002 | ||||||
| No | 78 | 84.8 | 9 | 52.9 | 69 | 92.0 | |||
| Yes | 14 | 15.2 | 8 | 47.1 | 6 | 8.0 | |||
Final model of New Caledonian cases of EM according to severity, n = 92.
| Variables | Total | Severe | Not severe | Adjusted OR | IC | P value | |||
|---|---|---|---|---|---|---|---|---|---|
| N = 92 | % | N = 29 | % | N = 63 | % | ||||
| Age | 1.01 | 1.004–1.01 | 0.001 | ||||||
| Mean (SD) | 25 | 34.2(22.7) | 20.7 (18) | ||||||
| Median (IQR) | 22.5 | 36 (27) | 15 (30.5) | ||||||
| Fever | 1.31 | 1.08–1.6 | 0.007 | ||||||
| No | 66 | 71.7 | 18 | 62.1 | 48 | 76.2 | |||
| Yes | 26 | 28.3 | 11 | 37.9 | 15 | 23.8 | |||
| Stiff neck | 0.8 | 0.7–1.006 | 0.06 | ||||||
| No | 70 | 76.1 | 27 | 93.1 | 43 | 68.3 | |||
| Yes | 22 | 23.9 | 2 | 6.9 | 20 | 6.9 | |||
| Convulsion | 1.48 | 1.1–1.9 | 0.006 | ||||||
| No | 82 | 89.1 | 23 | 79.3 | 59 | 93.7 | |||
| Yes | 10 | 10.9 | 6 | 20.7 | 4 | 6.3 | |||
| CSF glucose (g) | 1.09 | 0.99–1.2 | 0.08 | ||||||
| Mean (SD) | 2.73 | 2.9(1.04) | 2.63 (0.72) | ||||||
| Median (IQR) | 2.66 | 2.8 (1.15) | 2.6 (0.92) | ||||||
| Elevated CSF pressure | 1.4 | 1.06–1.84 | 0.01 | ||||||
| No | 83 | 90.2 | 24 | 82.8 | 59 | 93.7 | |||
| Yes | 9 | 9.8 | 5 | 17.2 | 4 | 6.3 | |||